People

Jeff Moore is listed by Oxford Science Enterprises as Senior Partner, Head of Life Sciences. The published affiliation belongs to the Life Sciences team or advisory category. Current directory reviewed October7,2026; exact appointment date is not established. Jeff Moore, also published as Jeffrey B. Moore and legally Jeffrey Bernard Moore, formerly led MP Healthcare Venture Management as President. Oxford Science Enterprises’ September 29, 2026 announcement confirms his move to Senior Partner and Head of Life Sciences and describes MPH as his preceding position. He led early-stage biotechnology investments from academic discovery to exit, including Covagen, F-star, Korro Bio, miRagen, Genocea and Trimtech. His current Oxford affiliation is preserved; historical MPH biographies must not be treated as proof of a current MPH presidency. He holds a DPhil from Oxford, an MBA from MIT and a biology degree from the University of New Brunswick; his career includes infectious-disease postdoctoral work at Harvard Medical School, Research Corporation Technologies, Millennium and Scriptgen. The exact final day of MPH employment is not established.
Roles
Senior Partner, Head of Life Sciences
Former President (by September 2026)
Former Non-Executive Director